erlotinib hydrochloride has been researched along with ispinesib in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (ispinesib) | Trials (ispinesib) | Recent Studies (post-2010) (ispinesib) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 57 | 11 | 34 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | ispinesib (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 4.1 | |
| Kinesin-like protein KIF11 | Homo sapiens (human) | 0.026 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 4.81 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Orazio, A; Reddy, K | 1 |
1 other study(ies) available for erlotinib hydrochloride and ispinesib
| Article | Year |
|---|---|
Highlights from the International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, And Clinical Applications, Philadelphia, PA, November 2005; ECCO 13--The European Cancer Conference, Paris, France, October 30-November 3, 2005.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bevacizumab; Clinical Trials as Topic; Erlotinib Hydrochloride; Female; Humans; Kinesins; Male; Neoplasms; Quinazolines; Vinblastine | 2005 |